On August 29, 2019 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that the company is scheduled to participate in the H.C. Wainwright 21st Annual Global Investment Conference in New York City (Press release, Ligand, AUG 29, 2019, View Source [SID1234539122]). Presentation takes place on Tuesday, September 10, 2019 at 8:45 a.m. Eastern Time. John Higgins, CEO, Matt Foehr, COO, and Matt Korenberg, CFO will attend for Ligand.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!